The FDA granted Mylan Pharmaceuticals approval to launch a generic version of Novartis' Lescol. The drug treats hypercholesterolemia and mixed dyslipidemia and also is a second-line preventive therapy for heart disease.
Mylan's generic Lescol receives FDA approval
SmartBrief Job Listings for Health Care
|Sr. Business Systems Analyst||
|Chief Operating Officer||
Presence Health Partners
|Des Plaines, IL|
|Leadership Recruiting Manager||
|Sr. Reimbursement Analyst||
Olympus America Inc.
|Sr. Report Developer Medical Claims||
Geisinger Health System